Fifty 410 review

The $133 figure requires a three-month purchase

Fifty 410 displays compounded tirzepatide starter treatment at $399 for three months, presented as $133 per month. Its high-dose package is $549, or $183 per month across that purchase. Those averages do not establish a flexible monthly subscription. The site also lists compounded semaglutide, but the reviewed public offer does not provide an equally clear price for it. Compare the amount committed today, the prescribed supply and the next purchase date. A package average is useful only when you can accommodate the upfront payment and its refund boundary.

Payment follows prescribing, not a promised approval

The current process describes a free initial clinician review, followed by choosing a pharmacy, dose and supply duration and paying if prescribed. No separate membership is required for that purchase. Clinical approval remains individual; a questionnaire or an attractive starter offer does not guarantee a prescription. Request the chosen formulation and dispensing pharmacy before paying. Different pharmacies and supply selections can create different quotes, so a general advertisement should not replace the itemized order you will actually receive.

Cancel before compounding begins

The September refund policy allows a full refund of a paid order before compounding starts. Once that work begins, ordinary cancellation and refunds are unavailable. A cancellation must be received and confirmed before the cutoff; sending a message does not itself establish that the order stopped. Ask which stage your order has reached and save the response. This boundary can precede shipping, so tracking that has not yet appeared is not proof that the order remains refundable. Budget accordingly if you are purchasing several months at once.

Delivery problems have a separate path

Wrong, lost, damaged or temperature-compromised shipments receive individual review for replacement, refund or credit. The policy asks for temperature concerns within forty-eight hours, supported by photographs. Preserve the package and seek pharmacy instructions before using a shipment you suspect is compromised. Eligible refunds require processing time plus the bank’s posting time; an approved request need not appear immediately on a card. These remedies address an order problem and do not create a general right to return prescription medicine that you decide not to continue.

An FDA warning letter remains relevant

In February 2026, the FDA sent a warning letter to Aspen Aesthetics doing business as Fifty 410 over misleading compounded-drug marketing, including implied preparation by the seller and approval implications. Current terms identify Aspen Aesthetics as the platform operator and independent clinicians and pharmacies as separate parties. Updated disclaimers do not establish regulatory clearance or closure of that letter. Compounded products are not FDA-approved. State eligibility, the assigned pharmacy and individual pregnancy, breastfeeding or postpartum considerations still need clinical confirmation; compare other reviews alongside the package price.